Sepúlveda, Juan Manuel <br/><br/>
Dacomitinib: an investigational drug for the treatment of glioblastoma.  [electronic resource] 

 -  Expert opinion on investigational drugs  Oct 2018 
 - 823-829 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>1744-7658 
<br/><br/><label>Standard No.: </label>10.1080/13543784.2018.1528225  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Drugs, Investigational--pharmacology<br/>ErbB Receptors--antagonists & inhibitors<br/>Gene Amplification<br/>Glioblastoma--drug therapy<br/>Humans<br/>Mutation<br/>Neoplasm Recurrence, Local<br/>Protein Kinase Inhibitors--pharmacology<br/>Quinazolinones--pharmacology<br/>Survival Rate